SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $390 | -9.9% | 14,147 | -1.7% | 0.02% | -5.9% |
| Q2 2023 | $433 | -17.4% | 14,391 | -0.6% | 0.02% | -22.7% |
| Q1 2023 | $524 | +1.2% | 14,472 | -0.3% | 0.02% | -4.3% |
| Q4 2022 | $518 | -99.9% | 14,522 | -17.6% | 0.02% | 0.0% |
| Q3 2022 | $597,000 | -7.2% | 17,626 | -20.7% | 0.02% | +21.1% |
| Q2 2022 | $643,000 | -10.3% | 22,232 | +0.2% | 0.02% | +11.8% |
| Q1 2022 | $717,000 | -3.5% | 22,187 | -12.9% | 0.02% | +13.3% |
| Q4 2021 | $743,000 | +9.9% | 25,468 | +0.4% | 0.02% | 0.0% |
| Q3 2021 | $676,000 | -17.0% | 25,360 | -4.1% | 0.02% | -6.2% |
| Q2 2021 | $814,000 | +24.3% | 26,450 | +5.7% | 0.02% | +23.1% |
| Q1 2021 | $655,000 | +28.7% | 25,020 | +23.6% | 0.01% | +18.2% |
| Q4 2020 | $509,000 | +20.6% | 20,247 | 0.0% | 0.01% | +10.0% |
| Q3 2020 | $422,000 | +17.5% | 20,247 | +34.1% | 0.01% | +11.1% |
| Q2 2020 | $359,000 | -64.3% | 15,099 | -50.4% | 0.01% | -59.1% |
| Q2 2019 | $1,007,000 | -7.7% | 30,436 | -2.2% | 0.02% | -8.3% |
| Q1 2019 | $1,091,000 | +5.5% | 31,127 | 0.0% | 0.02% | -7.7% |
| Q4 2018 | $1,034,000 | -39.1% | 31,127 | -7.7% | 0.03% | -23.5% |
| Q3 2018 | $1,698,000 | -39.9% | 33,727 | -28.5% | 0.03% | -41.4% |
| Q2 2018 | $2,824,000 | +23.9% | 47,192 | -5.2% | 0.06% | +28.9% |
| Q1 2018 | $2,279,000 | +14.9% | 49,759 | 0.0% | 0.04% | +15.4% |
| Q4 2017 | $1,983,000 | -0.4% | 49,759 | 0.0% | 0.04% | -11.4% |
| Q3 2017 | $1,990,000 | -9.2% | 49,759 | -2.2% | 0.04% | -6.4% |
| Q2 2017 | $2,192,000 | +37.7% | 50,859 | 0.0% | 0.05% | +34.3% |
| Q1 2017 | $1,592,000 | +15.9% | 50,859 | -6.5% | 0.04% | +9.4% |
| Q4 2016 | $1,374,000 | +1.2% | 54,418 | -0.9% | 0.03% | +14.3% |
| Q3 2016 | $1,358,000 | +16.2% | 54,893 | -4.4% | 0.03% | +3.7% |
| Q2 2016 | $1,169,000 | – | 57,411 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |